New onset migraine associated with use of soy isoflavone supplements.
Engel
Peter A
PA
Department of Medicine, Division of Geriatrics, Albany Medical College and the V.A. Medical Center, Albany, NY, USA. Peter.Engel@med.va.gov
D006801:Humans; D007529:Isoflavones / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D020325:Migraine with Aura / Q000139:chemically induced*; D030262:Soybean Proteins / Q000009:adverse effects*; D013025:Glycine max / Q000009:adverse effects*
D007529:Isoflavones; D030262:Soybean Proteins